Literature DB >> 8612582

The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products.

S T Wen1, P K Jackson, R A Van Etten.   

Abstract

c-Abl is a non-receptor protein-tyrosine kinase lacking a clear physiological role. A clue to its normal function is suggested by overexpression of Abl in fibroblasts, which leads to inhibition of cell growth. This effect requires tyrosine kinase activity and the Abl C-terminus. c-Abl is localized to the cell nucleus, where it can bind DNA, and interacts with the retinoblastoma protein, a potential mediator of the growth-inhibitory effect. Nuclear localization of Abl can be directed by a pentalysine nuclear localization signal in the Abl C-terminus. Here, we have identified two additional basic motifs in the Abl C-terminus, either of which can function independently of the pentalysine signal to localize Abl to the nucleus. Using a quantitative transfection assay, we show that both c-Abl and transforming Abl proteins inhibit entry into S phase and this effect is absolutely dependent on nuclear localization. Further, we demonstrate that the Abl cytostatic effect requires both the Rb and p53 tumor suppressor gene products. These results indicate that Abl inhibits cell proliferation by interacting with central elements of the cell cycle control apparatus in the nucleus, and suggest a direct connection between p53 and Rb in this growth-inhibitory pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612582      PMCID: PMC450068     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  81 in total

1.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.

Authors:  E Shtivelman; B Lifshitz; R P Gale; E Canaani
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

2.  BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.

Authors:  A J Muller; J C Young; A M Pendergast; M Pondel; N R Landau; D R Littman; O N Witte
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

3.  Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line.

Authors:  G Q Daley; R A Van Etten; P K Jackson; A Bernards; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

4.  Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.

Authors:  M Wetzler; M Talpaz; R A Van Etten; C Hirsh-Ginsberg; M Beran; R Kurzrock
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

5.  Biological response to phorbol ester determined by alternative G1 pathways.

Authors:  T S Huang; J Duyster; J Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

6.  Cell cycle arrest by tyrosine kinase Abl involves altered early mitogenic response.

Authors:  T Mattioni; P K Jackson; O Bchini-Hooft van Huijsduijnen; D Picard
Journal:  Oncogene       Date:  1995-04-06       Impact factor: 9.867

7.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

8.  Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.

Authors:  E P Reddy; M J Smith; A Srinivasan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

9.  Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants.

Authors:  P Jackson; D Baltimore; D Picard
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

10.  The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity.

Authors:  R A Van Etten; P K Jackson; D Baltimore; M C Sanders; P T Matsudaira; P A Janmey
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

View more
  57 in total

1.  c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.

Authors:  R V Sionov; S Coen; Z Goldberg; M Berger; B Bercovich; Y Ben-Neriah; A Ciechanover; Y Haupt
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  Interaction between UV-damaged DNA binding activity proteins and the c-Abl tyrosine kinase.

Authors:  Feng Cong; Jean Tang; Byung Joon Hwang; Bao Q Vuong; Gilbert Chu; Stephen P Goff
Journal:  J Biol Chem       Date:  2002-07-09       Impact factor: 5.157

3.  c-Abl mediates high NaCl-induced phosphorylation and activation of the transcription factor TonEBP/OREBP.

Authors:  Morgan Gallazzini; Ming-Jiun Yu; Ruwan Gunaratne; Maurice B Burg; Joan D Ferraris
Journal:  FASEB J       Date:  2010-06-28       Impact factor: 5.191

4.  Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein.

Authors:  Chae-Ryun Yi; Naomi Rosenberg
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

5.  The effects of c-Abl mutation on developing B cell differentiation and survival.

Authors:  Hans Brightbill; Mark S Schlissel
Journal:  Int Immunol       Date:  2009-03-19       Impact factor: 4.823

6.  Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor.

Authors:  J G Savory; B Hsu; I R Laquian; W Giffin; T Reich; R J Haché; Y A Lefebvre
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 7.  Abl tyrosine kinases in T-cell signaling.

Authors:  Jing Jin Gu; Jae Ryun Ryu; Ann Marie Pendergast
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

9.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

10.  c-Abl tyrosine kinase regulates cardiac growth and development.

Authors:  Zhaozhu Qiu; Yong Cang; Stephen P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.